Literature DB >> 28321483

Distribution of Kawasaki Disease Coronary Artery Aneurysms and the Relationship to Coronary Artery Diameter.

Etsuko Tsuda1, Nobuyuki Tsujii2, Kohji Kimura3, Atsuko Suzuki4.   

Abstract

We investigated how the diameter of coronary artery aneurysm (CAA) relates to the distribution immediately after Kawasaki disease (KD). Two hundred and four pts (155 males and 49 females) who had undergone selective coronary angiography (CAGs) less than 100 days after the onset of KD were studied. We measured the maximum diameter of each artery segment in the initial CAGs. We analyzed the relationship between the maximum diameters and the distribution of CAA. We divided the patients into four groups based on the maximum CAA diameter in each patient (large(L) ≥8 mm, medium(M) ≥6 and <8 mm, small(S) ≥4 and <6 mm, very small(VS) <4 mm) and counted the affected segments. There were 87, 61, 36, and 20 patients in groups L, M, S, VS, respectively. The number of segments with CAA in each group was L 6 ± 2, M 4 ± 2, S 2 ± 2, VS 2 ± 1. The number of affected segments in L was significantly more than M, and a large value for L indicated that involvement was significantly more likely to be bilateral. The larger the maximum diameter of CAA, the more extensive disease involvement and the more likely to be bilateral. A large maximum CAA can also indicate coronary involvement in the longitudinal directions. It is an important charcteristic in distribution of CAA caused by KD vasculitis.

Entities:  

Keywords:  Coronary artery aneurysm (CAA); Kawasaki disease (KD); Left coronary artery (LCA); Right coronary artery (RCA); Systemic artery aneurysm (SAA)

Mesh:

Year:  2017        PMID: 28321483     DOI: 10.1007/s00246-017-1599-4

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  13 in total

1.  Measurements of Coronary Artery Aneurysms Due to Kawasaki Disease by Dual-Source Computed Tomography (DSCT).

Authors:  Nobuyuki Tsujii; Etsuko Tsuda; Suzu Kanzaki; Kenichi Kurosaki
Journal:  Pediatr Cardiol       Date:  2015-10-29       Impact factor: 1.655

2.  ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease.

Authors:  Y Onouchi; Y Suzuki; H Suzuki; M Terai; K Yasukawa; H Hamada; T Suenaga; T Honda; A Honda; H Kobayashi; T Takeuchi; N Yoshikawa; J Sato; S Shibuta; M Miyawaki; K Oishi; H Yamaga; N Aoyagi; S Iwahashi; R Miyashita; Y Murata; R Ebata; K Higashi; K Ozaki; K Sasago; T Tanaka; A Hata
Journal:  Pharmacogenomics J       Date:  2011-10-11       Impact factor: 3.550

3.  A survey of the 3-decade outcome for patients with giant aneurysms caused by Kawasaki disease.

Authors:  Etsuko Tsuda; Kenji Hamaoka; Hiroyuki Suzuki; Hisanori Sakazaki; Yosuke Murakami; Masao Nakagawa; Hisashi Takasugi; Muneo Yoshibayashi
Journal:  Am Heart J       Date:  2013-11-06       Impact factor: 4.749

4.  Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Digest version.

Authors: 
Journal:  Circ J       Date:  2014-09-22       Impact factor: 2.993

5.  Standard method for ultrasound imaging of coronary artery in children.

Authors:  Shigeto Fuse; Tohru Kobayashi; Yoshio Arakaki; Shunichi Ogawa; Hitoshi Katoh; Naoko Sakamoto; Kenji Hamaoka; Tsutomu Saji
Journal:  Pediatr Int       Date:  2010-12       Impact factor: 1.524

6.  Characteristics and Fate of Systemic Artery Aneurysm after Kawasaki Disease.

Authors:  Shinsuke Hoshino; Etsuko Tsuda; Osamu Yamada
Journal:  J Pediatr       Date:  2015-05-14       Impact factor: 4.406

Review 7.  Kawasaki disease. With particular emphasis on arterial lesions.

Authors:  S Naoe; K Takahashi; H Masuda; N Tanaka
Journal:  Acta Pathol Jpn       Date:  1991-11

8.  Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1100 cases.

Authors:  A Suzuki; T Kamiya; N Kuwahara; Y Ono; T Kohata; O Takahashi; K Kimura; M Takamiya
Journal:  Pediatr Cardiol       Date:  1986       Impact factor: 1.655

9.  ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms.

Authors:  Yoshihiro Onouchi; Tomohiko Gunji; Jane C Burns; Chisato Shimizu; Jane W Newburger; Mayumi Yashiro; Yoshikazu Nakamura; Hiroshi Yanagawa; Keiko Wakui; Yoshimitsu Fukushima; Fumio Kishi; Kunihiro Hamamoto; Masaru Terai; Yoshitake Sato; Kazunobu Ouchi; Tsutomu Saji; Akiyoshi Nariai; Yoichi Kaburagi; Tetsushi Yoshikawa; Kyoko Suzuki; Takeo Tanaka; Toshiro Nagai; Hideo Cho; Akihiro Fujino; Akihiro Sekine; Reiichiro Nakamichi; Tatsuhiko Tsunoda; Tomisaku Kawasaki; Yusuke Nakamura; Akira Hata
Journal:  Nat Genet       Date:  2007-12-16       Impact factor: 38.330

10.  Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey.

Authors:  Yosikazu Nakamura; Mayumi Yashiro; Ritei Uehara; Atsuko Sadakane; Satoshi Tsuboi; Yasuko Aoyama; Kazuhiko Kotani; Enkh-Oyun Tsogzolbaatar; Hiroshi Yanagawa
Journal:  J Epidemiol       Date:  2012-03-10       Impact factor: 3.211

View more
  4 in total

1.  Coronary artery aneurysms of unknown origin in a 14-year-old girl.

Authors:  Yuka Toyoshima; Etsuko Tsuda; Yoshiaki Kato; Tohru Iwasa; Heima Sakaguchi; Yusuke Shimahara; Shinya Tabata; Taichi Ikedo; Isao Shiraishi; Kenichi Kurosaki
Journal:  J Cardiol Cases       Date:  2021-08-17

2.  Sudden Child Death due to Thrombotic Giant Coronary Artery Aneurysms Complicated by Atypical Kawasaki Disease: An Autopsy Case.

Authors:  DongJa Kim; Man-Hoon Han; SangHan Lee
Journal:  J Pathol Transl Med       Date:  2018-05-11

Review 3.  Significance of Coronary Revascularization for Coronary-Artery Obstructive Lesions Due to Kawasaki Disease.

Authors:  Soichiro Kitamura; Etsuko Tsuda
Journal:  Children (Basel)       Date:  2019-01-29

4.  Coronary sequelae of Kawasaki disease treated with rotational atherectomy and drug coated balloon: A case report.

Authors:  Yongfeng Shi; Longbo Li; Meijia Liu; Chunli Song; Junduo Wu; Bin Liu
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.